Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Neuroscience|May 4, 2023
Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer's disease and controlsChih-Hao Chen, Mary Klir Khnaijer, Andrew E Beaudin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisS Dahyun Park, Cheryl R McCreary, Myrlene Gee, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2022
Mediators of cognitive impairment in cerebral amyloid angiopathyRomella Durrani, Meng Wang, Emily Cox, et al.
Neurology|August 5, 2026
Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive SymptomsNikita Nukala, Ryan T Muir, Andrew E Beaudin, et al.
Frontiers in Aging Neuroscience|April 24, 2023
Dual-task gait and white matter hyperintensities in Lewy body diseases: An exploratory analysisIpinuoluwakiye Fatokun, Myrlene Gee, Krista Nelles, et al.
Journal of Neurology|October 30, 2023
Gray matter loss relates to dual task gait in Lewy body disorders and agingArsenije Subotic, Myrlene Gee, Krista Nelles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2025
Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controlsRyan T Muir, Sophie Stukas, Jennifer G Cooper, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersRyan T Muir, Andrew E Beaudin, Cheryl R McCreary, et al.
Neurology|February 25, 2022
Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid AngiopathyAndrew E Beaudin, Cheryl R McCreary, Erin L Mazerolle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersRichard Camicioli, Sandra E Black, Michael J Borrie, et al.
Pageof 12